143 related articles for article (PubMed ID: 15581417)
41. Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma.
Ma H; Jin S; Yang W; Zhou G; Zhao M; Fang S; Zhang Z; Hu J
Br J Cancer; 2018 Feb; 118(4):509-521. PubMed ID: 29348488
[TBL] [Abstract][Full Text] [Related]
42. JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa.
Boor PPC; de Ruiter PE; Asmawidjaja PS; Lubberts E; van der Laan LJW; Kwekkeboom J
Transl Res; 2017 Oct; 188():67-79. PubMed ID: 27931982
[TBL] [Abstract][Full Text] [Related]
43. Type I interferons activate apoptosis in a Jurkat cell variant by caspase-dependent and independent mechanisms.
Gamero AM; Potla R; Sakamoto S; Baker DP; Abraham R; Larner AC
Cell Signal; 2006 Aug; 18(8):1299-308. PubMed ID: 16337360
[TBL] [Abstract][Full Text] [Related]
44. Mechanisms of Interferon-alpha induced apoptosis in malignant cells.
Thyrell L; Erickson S; Zhivotovsky B; Pokrovskaja K; Sangfelt O; Castro J; Einhorn S; Grandér D
Oncogene; 2002 Feb; 21(8):1251-62. PubMed ID: 11850845
[TBL] [Abstract][Full Text] [Related]
45. Interferons activate the p42/44 mitogen-activated protein kinase and JAK-STAT (Janus kinase-signal transducer and activator transcription factor) signalling pathways in hepatocytes: differential regulation by acute ethanol via a protein kinase C-dependent mechanism.
Nguyen VA; Chen J; Hong F; Ishac EJ; Gao B
Biochem J; 2000 Jul; 349(Pt 2):427-34. PubMed ID: 10880341
[TBL] [Abstract][Full Text] [Related]
46. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
47. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of IFNalpha-1a-Induced Apoptosis in a Laryngeal Cancer Cell Line.
Xin XL; Zhang R; Yuan XM; Liu L
Med Sci Monit; 2019 Sep; 25():7100-7114. PubMed ID: 31542790
[TBL] [Abstract][Full Text] [Related]
49. Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways.
Caraglia M; Marra M; Tagliaferri P; Lamberts SW; Zappavigna S; Misso G; Cavagnini F; Facchini G; Abbruzzese A; Hofland LJ; Vitale G
Curr Cancer Drug Targets; 2009 Aug; 9(5):690-704. PubMed ID: 19508175
[TBL] [Abstract][Full Text] [Related]
50. Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha.
Brender C; Lovato P; Sommer VH; Woetmann A; Mathiesen AM; Geisler C; Wasik M; Ødum N
Leukemia; 2005 Feb; 19(2):209-13. PubMed ID: 15618960
[TBL] [Abstract][Full Text] [Related]
51. TWEAK signals through JAK-STAT to induce tumor cell apoptosis.
Chapman MS; Wu L; Amatucci A; Ho SN; Michaelson JS
Cytokine; 2013 Jan; 61(1):210-7. PubMed ID: 23107828
[TBL] [Abstract][Full Text] [Related]
52. Interferon alpha induces cell death through interference with interleukin 6 signaling and inhibition of STAT3 activity.
Thyrell L; Arulampalam V; Hjortsberg L; Farnebo M; Grandér D; Pokrovskaja Tamm K
Exp Cell Res; 2007 Nov; 313(19):4015-24. PubMed ID: 17880940
[TBL] [Abstract][Full Text] [Related]
53. Adenylate cyclase/cAMP pathway downmodulation counteracts apoptosis induced by IFN-alpha in human epidermoid cancer cells.
Naviglio S; Spina A; Marra M; Sorrentino A; Chiosi E; Romano M; Improta S; Budillon A; Illiano G; Abbruzzese A; Caraglia M
J Interferon Cytokine Res; 2007 Feb; 27(2):129-36. PubMed ID: 17316140
[TBL] [Abstract][Full Text] [Related]
54. Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes.
Radaeva S; Jaruga B; Hong F; Kim WH; Fan S; Cai H; Strom S; Liu Y; El-Assal O; Gao B
Gastroenterology; 2002 Apr; 122(4):1020-34. PubMed ID: 11910354
[TBL] [Abstract][Full Text] [Related]
55. Hepatitis C virus core protein modulates the interferon-induced transacting factors of Jak/Stat signaling pathway but does not affect the activation of downstream IRF-1 or 561 gene.
Basu A; Meyer K; Ray RB; Ray R
Virology; 2001 Sep; 288(2):379-90. PubMed ID: 11601909
[TBL] [Abstract][Full Text] [Related]
56. Smac mimetic sensitizes renal cell carcinoma cells to interferon-α-induced apoptosis.
Reiter M; Eckhardt I; Haferkamp A; Fulda S
Cancer Lett; 2016 May; 375(1):1-8. PubMed ID: 26912071
[TBL] [Abstract][Full Text] [Related]
57. Protein kinase ERK contributes to differential responsiveness of human myeloma cell lines to IFNalpha.
Song L; Li Y; Shen B
Cancer Cell Int; 2002 Jul; 2(1):9. PubMed ID: 12234375
[TBL] [Abstract][Full Text] [Related]
58. Antiproliferative action of interferon-alpha requires components of T-cell-receptor signalling.
Petricoin EF; Ito S; Williams BL; Audet S; Stancato LF; Gamero A; Clouse K; Grimley P; Weiss A; Beeler J; Finbloom DS; Shores EW; Abraham R; Larner AC
Nature; 1997 Dec; 390(6660):629-32. PubMed ID: 9403695
[TBL] [Abstract][Full Text] [Related]
59. Signaling via the interferon-alpha receptor in chronic myelogenous leukemia cells.
Verma A; Platanias LC
Leuk Lymphoma; 2002 Apr; 43(4):703-9. PubMed ID: 12153154
[TBL] [Abstract][Full Text] [Related]
60. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
Remacle-Bonnet MM; Garrouste FL; Heller S; André F; Marvaldi JL; Pommier GJ
Cancer Res; 2000 Apr; 60(7):2007-17. PubMed ID: 10766192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
